1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974. 54:271–276.
2. Do YS, Kim KW, Chun JK, Cha BH, Namgoong MK, Lee HY. Predicting factors for refractory Kawasaki disease. Korean Circ J. 2010. 40:239–242.
3. Laxer RM, Petty RE. Hyponatremia in Kawasaki disease. Pediatrics. 1982. 70:655.
4. Nakamura Y, Yashiro M, Uehara R, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int. 2004. 46:33–38.
5. Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol. 2006. 21:778–781.
6. Lim GW, Lee MN, Kim HS, Hong YM, Sohn SJ. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in Kawasaki disease. Korean Circ J. 2010. 40:507–513.
7. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. 1994. 79:934–939.
8. Ohta M, Ito S. Hyponatremia and inflammation. Rinsho Byori. 1999. 47:408–416.
9. Smith PK, Goldwater PN. Kawasaki disease in Adelaide: a review. J Paediatr Child Health. 1993. 29:126–131.
10. Shin JI, Kim JH, Lee JS, Kim DS, Choi JY, Sul JH. Kawasaki disease and hyponatremia. Pediatr Nephrol. 2006. 21:1490–1491.